BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 46.965 USD -1.52% Market Closed
Market Cap: 8.9B USD
Have any thoughts about
BridgeBio Pharma Inc?
Write Note

Wall Street
Price Targets

BBIO Price Targets Summary
BridgeBio Pharma Inc

Wall Street analysts forecast BBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BBIO is 61.38 USD with a low forecast of 42.42 USD and a high forecast of 99.75 USD.

Lowest
Price Target
42.42 USD
10% Downside
Average
Price Target
61.38 USD
31% Upside
Highest
Price Target
99.75 USD
112% Upside
BridgeBio Pharma Inc Competitors:
Price Targets
688278
Xiamen Amoytop Biotech Co Ltd
33% Upside
CRBU
Caribou Biosciences Inc
479% Upside
ANAB
AnaptysBio Inc
63% Upside
DVYSR
Devyser Diagnostics AB
24% Upside
MDXG
MiMedx Group Inc
93% Upside
IONS
Ionis Pharmaceuticals Inc
39% Upside

Revenue
Forecast

Revenue Estimate
BridgeBio Pharma Inc

The compound annual growth rate of BridgeBio Pharma Inc's revenue for the next 3 years is 78%.

N/A
Past Growth
78%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BridgeBio Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
BridgeBio Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BBIO's stock price target?
Price Target
61.38 USD

According to Wall Street analysts, the average 1-year price target for BBIO is 61.38 USD with a low forecast of 42.42 USD and a high forecast of 99.75 USD.

What is BridgeBio Pharma Inc's Revenue forecast?
Projected CAGR
78%

The compound annual growth rate of BridgeBio Pharma Inc's revenue for the next 3 years is 78%.

Back to Top